3mt 2022: amanda heiderscheit: a novel biomarker for chronic kidney disease: c3 glomerulopathy
Published 1 year ago • 196 plays • Length 2:10Download video MP4
Download video MP3
Similar videos
-
9:57
teclistamab, a bcma × cd3 bispecific antibody, in pts with rrmm: updated phase 1 results
-
6:37
ablation of barrett´s esophagus with hybridapc 2
-
1:35
hemocue parte 3
-
5:20
anti-cd3 collabody™
-
2:49
jafron tutorial - ha380 with prismaflex
-
10:58
ekf hemo control user training_malaysia
-
2:21
what foods trigger diverticulitis?
-
29:54
new pathways linking cholesterol efflux to inflammasome activation.
-
14:23
acuteabd3pcv2
-
16:00
acuteabd2cr
-
1:53
inhibition of c3 with apl-2 in autoimmune hemolytic anemia to reduce hemolysis
-
1:20
cystatin c.flv
-
1:59
tangible benefit for flt3-itd r/r aml on quizartinib
-
41:16
c3 glomerulopathy - erknet webinar with marina vivarelli
-
1:21
the role of tlr7 in kidney inflammation and fibrosis
-
0:56
cytokeratin positive interstitial reticulum cell tumour - without a ribbon
-
0:55
3d-immunofluorescence of a human ovarian cancer stained with cd326 (epcam) antibody
-
6:43
abo immunoadsorption using glycosorb (a column) @kidneycareforyou
-
25:30
hemolyzer 3 pro
-
1:29
bispecific bcma-cd3 antibody teclistamab is efficacious and tolerable in r/r mm
-
5:58
percutaneous cryoablation of renal cancer using the prosense system (short)
-
23:50
giant cell arteritis